| Followers | 0 |
| Posts | 307 |
| Boards Moderated | 0 |
| Alias Born | 07/28/2020 |
Tuesday, September 15, 2020 11:11:16 AM
Great Company ruined by dilution??? Where?
There are very few examples of companies that were truly stunted by dilution, but if that dilution financed their success then oh well right? That’s supposed to be the idea SH tell themselves in the long payout from a long hold. Oh well it was worth it in the end. The dilution satisfied the goal.
But that is not what has happened here folks...
This is not some GREAT COMPANY that has been ruined by dilution. This is a terrible company with WAY TOO MANY RED FLAGS FOR SOME TO BE DEFENDING IT THE WAY THEY ARE. Like it’s their friend or something. Like they know these 4 people or maybe they think they know the science or medicine involved.
THEY DONT.
And no amount of tiny pinhead livers or pinhead pancreas in a permeated cellulose bead is gonna take in enough of any chemo drug or produce enough insulin and spit it out in any meaningful proportion. As you will surely find in your research. Past studies showed this, at least suggested it, and unfortunately PMCB didn’t do any R and D so we don’t have any new information to use. So what else leads us to believe this is a scam?
There are very few examples of companies that were truly stunted by dilution, but if that dilution financed their success then oh well right? That’s supposed to be the idea SH tell themselves in the long payout from a long hold. Oh well it was worth it in the end. The dilution satisfied the goal.
But that is not what has happened here folks...
This is not some GREAT COMPANY that has been ruined by dilution. This is a terrible company with WAY TOO MANY RED FLAGS FOR SOME TO BE DEFENDING IT THE WAY THEY ARE. Like it’s their friend or something. Like they know these 4 people or maybe they think they know the science or medicine involved.
THEY DONT.
And no amount of tiny pinhead livers or pinhead pancreas in a permeated cellulose bead is gonna take in enough of any chemo drug or produce enough insulin and spit it out in any meaningful proportion. As you will surely find in your research. Past studies showed this, at least suggested it, and unfortunately PMCB didn’t do any R and D so we don’t have any new information to use. So what else leads us to believe this is a scam?
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
